Introduction

1
In the field of cell transplantation therapy, mesenchymal stem cells (MSCs) have been shown 2 to have a protective effect on islet cells (1,2). Cell sheets developed using tissue engineering help 3 maintain the function of the cells via a trophic effect (3, 4) . The protective effect of MSCs engineered 4 into a cell sheet is thus thought to be improved. In the present study, we attempted to create MSC 5 sheets co-cultured with islets as an approach to islet transplantation.
6
In islet transplantation recipients who have undergone an intraportal injection, the ability to 7 achieve long-term glycemic control remains insufficient (5). During intraportal transplantation, 8 60%-80% of the islets are lost within 1 h after transplantation due to immediate blood-mediated 9 inflammatory reactions (IBMIRs), activation by direct exposure to foreign immunological cells, and 10 the toxic effects of the immunosuppressive compounds on the transplanted islets (6). Additionally, an 11 insufficient blood supply and immunoreactions associated with intraportal islet transplantation are 12 primary causes of islet loss (6,7).
13
Several studies described the transplantation of islets at extrahepatic sites, including the 14 omentum (8), spleen (9), testes (10), and renal subcapsular space (11). However, a sufficient 15 long-term control of blood glucose levels has been not shown after implantation at these sites. In MSCs are known to differentiate into endothelial cells (14, 15) and improve the engraftment 3 of islets by secreting anti-apoptotic and angiogenic cytokines such as vascular endothelial growth 4 factor (VEGF), hepatocyte growth factor (HGF), and transforming factor beta 1 (TGFβ1) (16-18). The ECM provides the necessary structural and adhesive properties for maintaining cell sheet 10 integrity during transplantation. More recently, our group reported that human hepatic cell sheets 11 could be made rapidly and efficiency by using fibroblasts cells (19) . We propose that the protective 12 and engraftment effects of MSCs for transplanted islets could be improved by using MSCs 13 engineered into cell sheets.
14
In the present study we applied a tissue engineering approach using islets with MSC sheets 15 (islets + MSC sheet) for transplantation at subcutaneous sites. The purpose of this study was to 16 confirm the protective and therapeutic effects of using MSCs engineered into a cell sheet by tissue 17 engineering as a scaffold for islet cell transplantation at an extrahepatic site. Eight-week-old male Fischer 344 rats, 200-300-g male Fischer 344 rats, and 6-wk-old male 3 SCID mice (Charles River Laboratories Japan, Yokohama, Japan) were used.
4
This study was carried out in strict accordance with the recommendations in the Guide for We isolated bone marrow cells from the femurs of 8-wk-old rats by flushing the femurs with 10 alpha minimum essential medium (αMEM) (Invitrogen GIBCO, Carlsbad, CA, USA) containing 11 10% fetal bovine saline (FBS) (Invitrogen), 100 IU/mL penicillin (Invitrogen) and 100 μg/mL 12 streptomycin (Invitrogen). These MSCs were used for the experiments at passage two or three.
14
Characterization of the MSCs
15
Flow cytometry (FACS) analysis
16
The MSCs were prepared for use with the following markers: CD29, CD31, CD34, and Cruz Bio-Technology, Santa Cruz, CA), and FITC mouse anti-rat Thy-1/CD90 (LSBio). 
Differentiation of MSCs in vitro 7
We induced the differentiation of isolated MSCs into mesenchymal osteogenic and 
Isolation of islets
12
Fischer 344 rats (200-300 g) were used as donors for islet transplantation. The islets were 13 isolated using collagenase digestion according to published methods (21 For the insulin secretion assay, islets co-cultured with MSCs or an MSC sheet after 72 h of 4 incubation were preincubated for 1 h at 37°C with RPMI-1640 medium containing 3.3 mM glucose.
5
After preincubation step, the culture medium was changed to fresh RPMI-1640 containing 3.3 mM 6 glucose for an additional 1 h. The media were replaced with 20 mM glucose for 1 h. For the final 7 step, the medium was changed to 3.3 mM glucose for 1 h. The culture medium was collected and 8 frozen at −20°C until the analysis. The amount of secreted insulin was measured using an
9
Ultrasensitive Rat Insulin ELISA Kit (Morinaga Institute of Biological Science, Kanagawa, Japan).
10
The stimulation index (SI) was calculated as follows: SI = (insulin content in the 20 mM glucose 11 media)/(insulin content in the initial 3.3 mM glucose media).
13
Cytokine quantification 14 We measured the secretion of cytokines in the supernatants using the VEGF Rat ELISA Kit mice (n=5), and recipient mice were used: 2,000 islets alone (n=5), MSC sheet alone (n=5), 2,000 16 islets with MSCs (n=5), two islets + MSC sheets (1,000 islets) (n=5), and four islets + MSC sheets
17
(2,000 islets) (n=6). For an investigation of the long-term efficacy of the islets + MSC sheets,
18
another six mice were transplanted with four islets + MSC sheets (2,000 islets). 
Characteristics of MSCs isolated from rat bone marrow
13
The isolated cells were positive for the mesenchymal markers CD29 and CD90, and 14 negative for the hematopoietic markers CD31 and CD34 (Fig. 1A ). These findings indicated that the 15 characteristic immunophenotype of rat bone marrow-derived MSCs was exhibited in the isolated 16 cells (22-24). MSCs have differentiation ability into osteogenic and adipogenic lineages (22, 23).
17
The cells described herein are able to differentiate into osteocytes and adipocytes (Fig. 1B) .
19
Harvest of the islet + MSC sheets 1
The islets seeded on the MSC sheet immediately sank to the bottom of the culture dishes 2 and came into contact with the MSCs (Fig. 2A, B) . After a 72-h culture, the islets adhered to the 3 MSCs. The MSCs detached from the culture dish while shrinking slowly as a cell sheet following 4 low-temperature treatment (Fig. 2C, D) . The islets were confirmed on the sheet using dithizone 5 staining ( Fig. 2E ).
7
Histological assessment of the adherent islets in vitro 8 H&E staining showed that the islets adhered to the sheet while maintaining a spherical 9 shape in their physiological form. In addition (Fig. 2F ), the MSC sheets firmly adhered to the islets, 10 which demonstrated cytoplasmic immunostaining for both insulin and glucagon (Fig. 2G,H ).
12
Transmission electron microscopy
13
The islets adhered firmly to the MSC sheets and partially to the ECM (Fig. 2I, J) , forming 14 tight junctions (Fig. 2K) . The MSC sheets contained multiple cell layers (Fig. 2L ) that established 15 cell-to-cell connections via the formation of tight and gap junctions (Fig. 2M ).
17
Recovery rate of islets 18
After 24 h, there were no differences in the recovery rate among the islets co-cultured with 19 1 significantly improved in the co-cultured groups compared to the group of islets cultured alone.
2
There were no significant differences between the MSCs group and the MSC sheet group at 72-h 3 culture (Fig. 3) .
5
Viability of the islets 6 We assessed the viability of the islets using calcein-AM /PI staining. Viable cells were 7 stained in green, and dead cells were stained in red (Fig. 4A ). The MSCs were almost 100% viable in 8 the range observed. The 72-h viability of the co-cultured islets groups was significantly improved 9 compared to the islets cultured-alone group (Fig. 4B ). There were no significant differences between 10 the MSCs group and the MSC sheet group.
12
Insulin secretion assay of the islet function
13
In the co-culture with MSCs and MSC sheet groups, the SI values were significantly higher 14 than in the cultured-alone group. There were no significant differences between the MSCs group and 15 the MSC sheet group (Fig. 5 ).
17
Cytokine secretion
18
The VEGF, HGF, and TGFβ1 levels were significantly higher in the co-culture groups 19 compared to the cultured-alone islets group. The TGFβ1 level was significantly higher in the 1 co-culture with MSC sheet group than in the co-culture with MSCs group (Fig. 5) . Islets + MSC sheet transplantation was performed as described in the Materials and Methods 5 section (Fig. 6A ). In the recipient SCID mice treated with two islets + MSC sheet transplantation, 6 three of the five recipient mice had maintained normoglycemia 2 wks after transplantation, two of 7 the five recipient mice had maintained normoglycemia at 3 wks after transplantation, and all mice 8 became hyperglycemic more than 3 wks after transplantation. Therefore, four islets + MSC sheet 9 transplantation was performed. All recipient SCID mice returned to a normoglycemic state within 1 10 wk, whereas all sham-operated mice remained hyperglycemic. The transplantation of 2,000 islets 11 alone and that of the same numbers of islets with MSCs was performed within 24 h after islet 12 isolation. All recipient mice exhibited a minimal decrease in the NFBG level and remained 13 hyperglycemic. In the diabetic SCID mice transplanted with MSC sheets only, all mice remained 14 hyperglycemic (Fig. 6B ). The body weight as a clinical condition of recipient mice in the four 15 islets + MSC sheet transplantation group improved (Fig. 6C ). All recipient SCID mice treated with a 16 four islets + MSC sheet remained normoglycemic for 84 days, and the NFBG levels rose rapidly 17 after graft removal (Fig. 6D ). An IPGTT was performed in the recipient mice treated with four 18 islets + MSC sheets and control (nondiabetic naive) SCID mice. The blood glucose levels returned to normal levels after elevations at 15 and 30 min. (Fig. 6E) . Islets maintaining their physiological shape were also detected ( Fig. 7A ), although no islets were 7 apparent at the subcutaneous sites in the specimens in the islet transplantation alone group (data not 8 shown). A significant amount of insulin was seen in the four islets + MSC sheet transplantation 9 group compared to that observed in the DM-sham mice group. There was no significant difference 10 among the 2,000 islets, 2,000 islets with MSCs, two islets + MSC sheet transplantation, and the DM 11 sham-operated group (Fig. 7B ).
13
Angiogenesis associated with the transplantation of islets + MSC sheets
14
The numbers of detectable vessels in the MSC sheet and islets + MSC sheet groups were 15 significantly higher than in the sham-operated and islets alone groups. There was no significant 16 difference in the vessel numbers among DM sham-operated, islets alone, and islets with MSCs 17 groups (Fig. 8A, B ). ability of the MSCs should be evaluated in a future study using an immunocompetent animal model.
7
The successful improvement of the blood glucose levels in diabetic mice was reported in a 8 study using approx. 400-500 islets for portal vein islet transplantation (43). A marginal amount of 9 islets was detected following the transplantation of 1,000-2,000 islets using the islet + MSC sheet 10 procedure. The major reasons underlying these findings are thought to be: 17. Aksu, A.E., Horibe, E., Sacks, J., Ikeguchi, R., Breitinger, J., Scozio, M., Unadkat, J., 19. Sakai, Y., Koike, M., Hasegawa, H., Yamanouchi, K., Soyama, A., Takatsuki, M., Kuroki, T., Ohashi, K., Okano, T., andEguchi, S. Rapid fabricating technique for multi-layered human 21. Okamoto, T., Kuroki, T., Adachi, T., Ono, S., Hayashi, T., Tajima, Y., Eguchi, S., andKanematsu,
12
T. Effect of zinc on early graft failure following intraportal islet transplantation in rat recipients. 29. Block, G.J., Ohkouchi, S., Fung, F., Frenkel, J., Gregory, C., Pochampally, R., DiMattia, G., calculated in the cultured-alone group and co-cultured with MSCs and MSC sheet groups. n=5 each.
10
The secretions of VEGF, HGF, and TGFβ1 in the supernatants obtained from the islets alone, islets 11 co-cultured with MSCs, and MSC sheets groups. n=5 each. *P<0.05, **P<0.01. islets + MSC sheets (1,000 islets) (n=5), and four islets + MSC sheets (2,000 islets) (n=6 islets + MSC sheets (1,000 islets) (n=5), four islets + MSC sheets (2,000 islets) (n=6)], and normal 12 SCID mice (n=7). **P<0.01 compared to the DM-Sham group. treated with islets alone (n=5), four MSC sheets alone (n=5), 2,000 islets with MSCs (n=5), and four
